The $2 billion multi-agency package announced yesterday will help revitalise new listings on the Singapore stock market, but an extra push may be required to whet local investor appetite for high-growth and high-tech companies that have been uncommon on the bourse here.
Financial experts said the stars may be aligning for the local market as many companies in the medtech, biotech, fintech and sustainability space, as well as potential future leaders in healthcare and industrial sectors in Singapore and across the region, are looking for a home.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you